Enanta Pharmaceuticals Inc.

Biotechnology • Healthcare • Watertown, MA, United States • ENTA (NMS)

Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for virology and immunology indications. The company's product pipeline comprises EDP-514, which is in phase 1b clinical development for the treatment of chronic infection with hepatitis B virus or HBV; zelicapavir and EDP-323, which is in phase II clinical development for the treatment of respiratory syncytial virus; EDP-235, which is in phase II clinical development for the treatment of human coronaviruses; and Glecaprevir, which is in the market for the treatment of chronic infection with hepatitis C virus or HCV. It has a collaborative development and license agreement with Abbott Laboratories to develop, manufacture, and commercialize HCV NS3 and NS3/4A protease inhibitor compounds, including paritaprevir and glecaprevir. The company was incorporated in 1995 and is headquartered in Watertown, Massachusetts.

Stock Performance (90 Days)

Data through Dec 24, 2025

Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

Enanta Pharmaceuticals Insider Ups Holding During Year - Yahoo Finance

Yahoo Finance • Jan 1

Enanta stock doubles despite RSV trial missing primary endpoint - Clinical Trials Arena

Clinical Trials Arena • Sep 30

Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Stock Catapults 27% Though Its Price And Business Still Lag The Industry - simplywall.st

simplywall.st • Dec 20

Enanta Pharmaceuticals Stock Rises 58% – Here’s An Important Update - Stocktwits

Stocktwits • Sep 29

Enanta Pharmaceuticals Announces Proposed Public Offering of Common Stock - Business Wire

Business Wire • Sep 30

Other Biotechnology Companies

Vertex Pharmaceuticals Inc. / MA

$118.68B market cap

Regeneron Pharmaceuticals, Inc.

$82.72B market cap

Alnylam Pharmaceuticals, Inc.

Frequently Asked Questions

Has ENANTA PHARMACEUTICALS INC had layoffs?

No layoff events have been recorded for ENANTA PHARMACEUTICALS INC in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.

How many employees does ENANTA PHARMACEUTICALS INC have?

ENANTA PHARMACEUTICALS INC has approximately 120 employees.

What industry is ENANTA PHARMACEUTICALS INC in?

ENANTA PHARMACEUTICALS INC operates in the Biotechnology industry, within the Healthcare sector.

Is ENANTA PHARMACEUTICALS INC a publicly traded company?

Yes, ENANTA PHARMACEUTICALS INC is publicly traded under the ticker symbol ENTA on the NMS. The company has a market capitalization of approximately $0.48 billion.

Where is ENANTA PHARMACEUTICALS INC headquartered?

ENANTA PHARMACEUTICALS INC is headquartered in Watertown, MA, United States.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.